These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 4008638)

  • 41. Differences between ocular and generalized myasthenia gravis: binding characteristics of anti-acetylcholine receptor antibody against bovine muscles.
    Hayashi M; Kida K; Yamada I; Matsuda H; Tsuneishi M; Tamura O
    J Neuroimmunol; 1989 Feb; 21(2-3):227-33. PubMed ID: 2913046
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis.
    Shiraishi H; Motomura M; Yoshimura T; Fukudome T; Fukuda T; Nakao Y; Tsujihata M; Vincent A; Eguchi K
    Ann Neurol; 2005 Feb; 57(2):289-93. PubMed ID: 15668981
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Functional inhibition of acetylcholine receptors by antibodies in myasthenic sera.
    Hall ZW; Pizzighella S; Gu Y; Vicini S; Schuetze SM
    Ann N Y Acad Sci; 1987; 505():272-85. PubMed ID: 2446552
    [No Abstract]   [Full Text] [Related]  

  • 44. The role of humoral and cellular immune factors in neuromuscular block in myasthenia gravis.
    Namba T; Nakata Y; Grob D
    Ann N Y Acad Sci; 1976; 274():493-515. PubMed ID: 786115
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Acetylcholine receptor antibody characteristics in myasthenia gravis. III. Patients with low anti-AChR antibody levels.
    Vincent A; Newsom-Davis J
    Clin Exp Immunol; 1985 Jun; 60(3):631-6. PubMed ID: 2410169
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of sera from myasthenia gravis patients on acetylcholine receptors in myotube cultures.
    Hudgson P; McAdams MW; Pericak-Vance MA; Edwards TM; Roses AD
    J Neurol Sci; 1983 Apr; 59(1):37-45. PubMed ID: 6854343
    [No Abstract]   [Full Text] [Related]  

  • 47. Effects of cytokines on acetylcholine receptor expression: implications for myasthenia gravis.
    Poëa-Guyon S; Christadoss P; Le Panse R; Guyon T; De Baets M; Wakkach A; Bidault J; Tzartos S; Berrih-Aknin S
    J Immunol; 2005 May; 174(10):5941-9. PubMed ID: 15879086
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Kinetic studies on neurotoxin-binding inhibitory antibodies in myasthenia gravis.
    Ito A; Furukawa S; Satoyoshi E; Sakurai H
    Clin Chim Acta; 1985 Nov; 152(3):315-23. PubMed ID: 2998645
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association of beta-cytoplasmic actin with high concentrations of acetylcholine receptor (AChR) in normal and anti-AChR-treated primary rat muscle cultures.
    Lubit BW
    J Histochem Cytochem; 1984 Sep; 32(9):973-81. PubMed ID: 6379042
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunochemical properties of junctional and extrajunctional acetylcholine receptor.
    Dwyer DS; Bradley RJ; Furner RL; Kemp GE
    Brain Res; 1981 Jul; 217(1):23-40. PubMed ID: 6167329
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Autoantibodies detected in acetylcholine receptor antibody-negative myasthenia gravis].
    Ohta R; Motomura M
    Rinsho Byori; 2014 Mar; 62(3):255-60. PubMed ID: 24800501
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neonatal myasthenia gravis: a new clinical and immunologic appraisal on 30 cases.
    Morel E; Eymard B; Vernet-der Garabedian B; Pannier C; Dulac O; Bach JF
    Neurology; 1988 Jan; 38(1):138-42. PubMed ID: 3336445
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Accelerated degradation of acetylcholine receptor from cultured rat myotubes with myasthenia gravis sera and globulins.
    Appel SH; Anwyl R; McAdams MW; Elias S
    Proc Natl Acad Sci U S A; 1977 May; 74(5):2130-4. PubMed ID: 266734
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mechanisms of acetylcholine receptor loss in myasthenia gravis.
    Drachman DB; Adams RN; Stanley EF; Pestronk A
    J Neurol Neurosurg Psychiatry; 1980 Jul; 43(7):601-10. PubMed ID: 6249894
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Exacerbated muscle dysfunction by procainamide in rats with experimental myasthenia gravis.
    Yeh TM; Tami JA; Krolick KA
    Drug Chem Toxicol; 1992; 15(1):53-65. PubMed ID: 1555523
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Muscle satellite cells are functionally impaired in myasthenia gravis: consequences on muscle regeneration.
    Attia M; Maurer M; Robinet M; Le Grand F; Fadel E; Le Panse R; Butler-Browne G; Berrih-Aknin S
    Acta Neuropathol; 2017 Dec; 134(6):869-888. PubMed ID: 28756524
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Molecular biology and immunology of acetylcholine receptor in relation to myasthenia gravis].
    Takamori M; Komai K; Iwasa K; Yoshikawa H
    Nihon Rinsho; 1997 Dec; 55(12):3315-21. PubMed ID: 9436457
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An enzyme-linked immunoabsorbent assay for measuring antibodies against muscle acetylcholine receptor.
    Dwyer DS; Bradley RJ; Urquhart CK; Kearney JF
    J Immunol Methods; 1983 Feb; 57(1-3):111-9. PubMed ID: 6827098
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Myasthenic globulin enhances the loss of acetylcholine receptor clusters.
    Bursztajn S; McManaman JL; Elias SB; Appel SH
    Science; 1983 Jan; 219(4581):195-7. PubMed ID: 6849132
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Age-related resistance to experimental autoimmune myasthenia gravis in rats.
    Graus YM; Verschuuren JJ; Spaans F; Jennekens F; van Breda Vriesman PJ; De Baets MH
    J Immunol; 1993 May; 150(9):4093-103. PubMed ID: 8386206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.